China Drug-Buying Overhaul Triggers a Flood of Profit Warnings

(Bloomberg) -- China’s drive to cut health-care costs is taking a toll on the profits of its drugmakers.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.